Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@genomics-online.com

Human CD44 ORF Clone in Lenti Particles (GFP tag)

This is a CD44 plasmid from OriGene with ORF insert cloned into Lentiviral VectorpLenti-C-mGFP. Insert length: not_set. Transient expression. Suitable for PExp. Bacterial selection: Chloramphenicol.
OriGene
Catalog No. ABIN6423460
Supplier Product No.: rc221771l2v
$1,553.31
Plus shipping costs $50.00, if applicable $20.00 dry ice
200 μL
Shipping to: United States
Delivery in 21 to 27 Business Days

Quick Overview for Human CD44 ORF Clone in Lenti Particles (GFP tag) (ABIN6423460)

Gene

CD44

Fusion tag

GFP tag

Application

Protein Expression (PExp)

Insert

ORF

Vector

Lentiviral Vector

Vector Backbone

pLenti-C-mGFP

Promoter

CMV Promoter

Bacterial Resistance

Chloramphenicol

Expression Type

Transient
  • Species

    Human

    Supplier Product No.

    rc221771l2v

    Supplier

    OriGene

    Purpose

    Lenti ORF particles, CD44 (mGFP-tagged) - Human CD44 molecule (Indian blood group) (CD44), transcript variant 1

    Specificity

    This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene.

    Characteristics

    • Broad cell spectrum: Lentivirus infect many cells, dividing & non-dividing, easy-to-transfect & hard-to-transfect cells.
    • High transduction efficiency.
    • Convenience: Minimal need for optimization.
    • Safety: 3rd generation system with improved biosafety.

    • Pre-titered, ready-to-use
    • Titer guaranteed, 10^7 TU/mL
    • Provided in the proprietary Lenti Stabilizer Solution with 1 year infectivity

    Components

    Lentiviral particles with guaranteed titer of >10^7 TU/mL
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Viral Particles

    Storage

    -80 °C

    Expiry Date

    12 months
  • Target

    CD44

    Alternative Name

    CD44
You are here: